Evidence map›Paper›PMID 40425051›Full record

SynthesisJornal de pediatria

Comparison between the safety of the HPV vaccine versus placebo: a systematic review and meta-analysis of randomized clinical trials.

Swelen Aparecida Dos Santos, Mariane Yoshie Sato, Pedro Henrique Gunha Basilio, Meire Ellen Pereira, Rafaela Climaco Julião, Nielson da Cunha Arruda, Davi Paula da Silva, Cláudia Sirlene Oliveira, Victor Horacio de Souza Costa-Junior, Izonete Cristina Guiloski

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Jornal de pediatria. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Swelen Aparecida Dos SantosInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil; Unicesumar, Curitiba, PR, Brazil.
Mariane Yoshie SatoInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Pedro Henrique Gunha BasilioInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Meire Ellen PereiraInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Rafaela Climaco JuliãoInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Nielson da Cunha ArrudaUnicesumar, Curitiba, PR, Brazil.
Davi Paula da SilvaInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Cláudia Sirlene OliveiraInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.
Victor Horacio de Souza Costa-JuniorHospital Pequeno Príncipe, Curitiba, PR, Brazil.
Izonete Cristina GuiloskiInstituto de Pesquisas Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil. Electronic address: izonete.guiloski@professor.fpp.edu.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHuman Papillomavirus (HPV) is a virus that targets epithelial tissues. Virtually all cases of cervical cancer are related to HPV, emphasizing the importance of vaccines in prevention. Although >200 million doses have been administered worldwide, concerns persist about adverse reactions. This study evaluated the safety of the HPV vaccine and the main adverse effects. DATA SOURCES: The study was registered in the PROSPERO database (CRD42023365692). The systematic searches were conducted in the PubMed, Scopus, Embase, Cochrane, Science Direct, and Web of Science databases using the search strategy "HPV" AND "vaccine" AND "safety" NOT "COVID" from 01/01/2007 to 31/12/2022. Inclusion criteria were based on the PICOT strategy, focusing on studies with humans, vaccinated populations comprising children, adolescents, and adults, and Phase II/III randomized clinical trials. The PEDro scale was used to assess the quality of the studies. SUMMARY OF

findingsEleven articles were qualified for qualitative synthesis and meta-analysis. The results indicated that HPV vaccination was associated with increased local reactions, fatigue, and myalgia compared to the placebo. However, there were no significant differences in serious adverse events, gastrointestinal reactions, cutaneous effects, headache, or fever between the vaccine and placebo groups.

conclusionLocal reactions, fatigue, and myalgia were more prevalent in the HPV vaccine group; the overall safety profile of the vaccine was favorable. The HPV vaccine was deemed safe, mirroring the profile of adverse reactions seen with other vaccines. With its potential to prevent cancer, the benefits of HPV vaccination far outweigh the minimal risks.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdolescentAdultChildHumansPlacebosRandomized Controlled Trials as TopicUterine Cervical NeoplasmsYoung AdultPapillomavirus VaccinesPlacebosImmunizationPapillomavirus infectionsUterine cervical neoplasms

Identifiers

PMID40425051
PMCPMC12495592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.